Scarica l'app Stockscreener
170.80
1.26%
1.95
Precedente Chiudi:
$168.85
Aprire:
$169.98
Volume 24 ore:
495.82K
Relative Volume:
0.31
Capitalizzazione di mercato:
$28.93B
Reddito:
$15.90B
Utile/perdita netta:
$1.28B
Rapporto P/E:
23.45
EPS:
7.2842
Flusso di cassa netto:
$2.21B
1 W Prestazione:
-8.81%
1M Prestazione:
-29.23%
6M Prestazione:
-10.12%
1 anno Prestazione:
-12.79%
Intervallo 1D:
$165.60
$172.52
Intervallo di 1 settimana:
$156.66
$194.83
Portata 52W:
$134.65
$247.04
Iqvia Holdings Inc Stock (IQV) Company Profile
Nome
Iqvia Holdings Inc
Settore
Industria
Telefono
919-998-2000
Indirizzo
2400 ELLIS ROAD, DURHAM, NC
Compare IQV vs TMO, DHR, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IQV
Iqvia Holdings Inc
|
170.57 | 28.64B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
TMO
Thermo Fisher Scientific Inc
|
507.01 | 191.54B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
213.69 | 151.94B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
634.24 | 49.28B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
126.44 | 35.32B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
323.48 | 31.37B | 3.17B | 642.63M | 539.81M | 10.77 |
Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-11-13 | Iniziato | BMO Capital Markets | Outperform |
| 2025-11-03 | Downgrade | TD Cowen | Buy → Hold |
| 2025-10-29 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-10-09 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2025-09-09 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-04-25 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-04-10 | Downgrade | Barclays | Overweight → Equal Weight |
| 2025-02-03 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-12-20 | Iniziato | Stephens | Overweight |
| 2024-10-14 | Iniziato | Redburn Atlantic | Buy |
| 2024-09-04 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-07-24 | Downgrade | Jefferies | Buy → Hold |
| 2024-06-06 | Iniziato | Goldman | Buy |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-02-15 | Downgrade | Guggenheim | Buy → Neutral |
| 2024-02-13 | Iniziato | BTIG Research | Buy |
| 2023-11-02 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2023-09-06 | Iniziato | HSBC Securities | Buy |
| 2023-03-17 | Iniziato | Truist | Buy |
| 2022-12-06 | Iniziato | Cowen | Outperform |
| 2022-11-17 | Downgrade | Citigroup | Buy → Neutral |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-07-15 | Iniziato | SVB Leerink | Outperform |
| 2022-05-24 | Iniziato | Guggenheim | Buy |
| 2022-04-29 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-04-16 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2021-03-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2020-07-07 | Iniziato | Stephens | Equal-Weight |
| 2020-03-02 | Iniziato | Deutsche Bank | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-12-13 | Aggiornamento | CFRA | Sell → Hold |
| 2019-11-14 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2019-06-21 | Aggiornamento | Mizuho | Neutral → Buy |
| 2019-05-28 | Iniziato | SVB Leerink | Outperform |
| 2019-01-18 | Aggiornamento | Jefferies | Hold → Buy |
| 2018-10-09 | Iniziato | UBS | Buy |
| 2018-10-02 | Reiterato | Robert W. Baird | Outperform |
| 2018-07-25 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2018-07-25 | Reiterato | Stifel | Buy |
| 2018-07-03 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2018-04-13 | Aggiornamento | Goldman | Neutral → Buy |
| 2018-03-07 | Aggiornamento | SunTrust | Hold → Buy |
| 2018-01-19 | Iniziato | Evercore ISI | Outperform |
Mostra tutto
Iqvia Holdings Inc Borsa (IQV) Ultime notizie
US prescriptions for Novo's Wegovy pill were 38,220 (not '38,909') for week ended Feb 6IQVIA data shared by analyst shows - marketscreener.com
Rhumbline Advisers Sells 25,227 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
The Top 5 Analyst Questions From IQVIA's Q4 Earnings Call - Finviz
Earnings growth of 3.6% over 3 years hasn't been enough to translate into positive returns for IQVIA Holdings (NYSE:IQV) shareholders - Yahoo Finance
75,170 Shares in IQVIA Holdings Inc. $IQV Purchased by Eubel Brady & Suttman Asset Management Inc. - MarketBeat
IQVIA Holdings Inc (IQV) Shares Gap Down to $186.065 on Feb 10 - GuruFocus
Global obesity trials get boost from new IQVIA–Duke research pact - Stock Titan
Compagnie Lombard Odier SCmA Cuts Stake in IQVIA Holdings Inc. $IQV - MarketBeat
Aug EndMonth: Is IQVIA Holdings Inc stock influenced by commodity pricesTrade Performance Summary & Community Verified Swing Trade Signals - baoquankhu1.vn
IQVIA revenue for Q4 2025 up 10.3% to USD 4,364M - Medical Buyer
Candriam S.C.A. Grows Position in IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA Holdings Inc. Stock Outperforms Competitors On Strong Trading Day - Longbridge
IQVIA Expands AI Data Partnerships As Investors Weigh Growth Prospects - Yahoo Finance
Rally Mode: Is Vipshop Holdings Limited Depositary Receipt subject to activist investor interestQuarterly Growth Report & Real-Time Volume Spike Alerts - baoquankhu1.vn
IQVIA Holdings (IQV) Valuation Check After Profit Guidance Disappoints Despite Solid Quarterly Revenue Beat - Sahm
Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), Haemonetics (HAE) and Denali Therapeutics (DNLI) - The Globe and Mail
Analysts Have Conflicting Sentiments on These Healthcare Companies: IQVIA Holdings (IQV) and Molina Healthcare (MOH) - The Globe and Mail
Thrivent Financial for Lutherans Has $5.76 Million Holdings in IQVIA Holdings Inc. $IQV - MarketBeat
Envestnet Asset Management Inc. Boosts Holdings in IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA Fell 19% This Week. Could Shares Push Toward $260 in 2026? - TIKR.com
Jefferies lowers IQVIA stock price target to $255 on margin pressures By Investing.com - Investing.com South Africa
IQVIA Leans On AI And Boehringer Deal As Shares Struggle - Sahm
IQVIA Q4 Earnings Call Highlights - Yahoo Finance
Jefferies lowers IQVIA stock price target to $255 on margin pressures - Investing.com UK
IQV: JP Morgan Lowers Price Target While Maintaining Overweight Rating | IQV Stock News - GuruFocus
IQVIA stock price target lowered to $225 by Evercore ISI amid AI concerns By Investing.com - Investing.com Australia
UBS Adjusts IQVIA Holdings (IQV) Price Target to $240 Amidst Ste - GuruFocus
Jefferies Lowers Price Target for IQVIA Holdings (IQV) to $255 | - GuruFocus
IQV Analyst Rating Update: Stifel Lowers Price Target to $220 | IQV Stock News - GuruFocus
Barclays Analyst Lowers Price Target for IQV to $210 | IQV Stock News - GuruFocus
Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term - Yahoo Finance
Leerink Partners Adjusts Price Target on IQVIA Holdings to $228 From $256, Maintains Outperform Rating - marketscreener.com
Evercore ISI Adjusts Price Target on IQVIA Holdings to $225 From $250, Maintains Outperform Rating - marketscreener.com
Barclays Adjusts IQVIA Price Target to $210 From $230, Maintains Equal Weight Rating - marketscreener.com
JPMorgan Adjusts IQVIA Price Target to $225 From $255, Maintains Overweight Rating - marketscreener.com
Citigroup Adjusts IQVIA Price Target to $200 From $230, Maintains Neutral Rating - marketscreener.com
IQV Q4 Deep Dive: Market Cautions Despite Revenue Beat and AI Strategy Emphasis - Finviz
TD Waterhouse Canada Inc. Sells 16,903 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA Holdings Inc. (NYSE:IQV) Q4 2025 Earnings Call Transcript - Insider Monkey
Jefferies Adjusts Price Target on IQVIA Holdings to $255 From $270, Maintains Buy Rating - marketscreener.com
Stifel Adjusts Price Target on IQVIA Holdings to $220 From $273, Maintains Buy Rating - marketscreener.com
IQVIA stock price target lowered to $225 by Evercore ISI amid AI concerns - Investing.com Nigeria
Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), Omnicell (OMCL) and MiMedx Group (MDXG) - The Globe and Mail
IQVIA Slipped 1% on AI Pivot: Why the Stock Could Rebound to $303 in 2026? - TIKR.com
Research Alert: CFRA Maintains Buy Rating On Shares Of Iqvia Holdings Inc. - 富途牛牛
IQVIA Q4 2025 slides: Revenue jumps 10.3%, stock falls despite beat - Investing.com Nigeria
IQVIA (IQV) Stock Trades Down, Here Is Why - Finviz
IQVIA Holdings (IQV) Q4 2025 Earnings Call Transcript - Fortune
IQVIA Holdings Inc. stock underperforms Thursday when compared to competitors - MarketWatch
IQVIA Q4 Earnings & Revenues Beat Estimates, Increase Y/Y - The Globe and Mail
IQVIA Holdings Inc (IQV) Q4 2025 Earnings Call Highlights: Stron - GuruFocus
Iqvia Holdings Inc Azioni (IQV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):